Impact of Containment and the Current Epidemic on the Sexual Risk-taking of People Using PrEP to Prevent HIV Infection.
CoroPrEP
1 other identifier
observational
96
1 country
1
Brief Summary
People using PrEP to prevent HIV infection have sexual risk-taking behaviors that motivated the prescription of PrEP. Both containment and the current epidemic may affect the sexual behavior of people using PrEP and the risk of acquiring STIs. Hypotheses regarding the impact of the current epidemic-motivated confinement and its gradual lifting are as follows:
- A decrease in sexual risk-taking during the confinement period, followed by an increase when the confinement is lifted.
- An increase in sexual violence and the use of psychoactive substances.
- An impact on PrEP monitoring and compliance.
- An increase in the incidence of STIs when the confinement is lifted.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 16, 2021
CompletedFirst Submitted
Initial submission to the registry
February 23, 2021
CompletedFirst Posted
Study publicly available on registry
February 26, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 16, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2022
CompletedMay 10, 2022
May 1, 2022
1.1 years
February 23, 2021
May 9, 2022
Conditions
Outcome Measures
Primary Outcomes (3)
Impact of the current epidemic on sexual risk taking of Prep users in the number of partners per month
At day 1
Impact of the current epidemic on sexual risk taking of Prep users in the number of sexual encounters per month
At day 1
Impact of the current epidemic on sexual risk taking of Prep users in the frequency of condom use during anal intercourse
At day 1
Study Arms (1)
PrEP patients undergoing follow-up at Tourcoing hospital
Interventions
Eligibility Criteria
The study will be conducted in all persons using PrEP as prevention against HIV infection undergoing follow-up at Tourcoing Hospital and receiving counseling during months of inclusion.
You may qualify if:
- People using PrEP for HIV prevention being followed up at Tourcoing hospital
- Having given their consent to participate in this study
- Beneficiary of a social insurance plan or entitled person
You may not qualify if:
- Minor patient
- Refusal to participate
- Trusteeship
- Curatorship
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CH Tourcoing
Tourcoing, France
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Agnes Meybeck, MD
CH TOURCOING
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 23, 2021
First Posted
February 26, 2021
Study Start
February 16, 2021
Primary Completion
March 16, 2022
Study Completion
September 1, 2022
Last Updated
May 10, 2022
Record last verified: 2022-05